BCAX insider transactions
Bicara Therapeutics Inc. (BCAX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for BCAX
- Chief Financial Officer Hyep Ivan exercised 9,200 shares at a strike of $3.79 and sold $187,883 worth of shares (9,200 units at $20.42) as part of a pre-agreed trading plan (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Executive Officer Mazumdar Claire exercised 15,000 shares at a strike of $3.79 and sold $300,579 worth of shares (15,000 units at $20.04) as part of a pre-agreed trading plan (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan exercised 8,000 shares at a strike of $3.79 and sold $253,649 worth of shares (12,500 units at $20.29) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 191,641 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Schelman William4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 3 filed by new insider Schelman William3 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Medical Officer Raben David exercised 5,500 shares at a strike of $3.79 and sold $125,830 worth of shares (5,500 units at $22.88) as part of a pre-agreed trading plan (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Hyep Ivan4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Mazumdar Claire4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Cohlhepp Ryan4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Raben David4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Hyep Ivan4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Mazumdar Claire4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan sold $245,714 worth of shares (12,500 units at $19.66) and exercised 8,000 shares at a strike of $3.79, decreasing direct ownership by 2% to 200,641 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Bicara Therapeutics Inc.4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Executive Officer Mazumdar Claire exercised 8,234 shares at a strike of $3.79 and sold $154,325 worth of shares (8,234 units at $18.74) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan exercised 12,892 shares at a strike of $3.79 and sold $315,893 worth of shares (17,392 units at $18.16), decreasing direct ownership by 2% to 205,141 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Financial Officer Hyep Ivan exercised 16,518 shares at a strike of $3.79 and sold $300,971 worth of shares (16,518 units at $18.22) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Medical Officer Raben David exercised 16,500 shares at a strike of $3.79 and sold $305,610 worth of shares (16,500 units at $18.52) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Director Ra Capital Management, L.P. bought $4,800,000 worth of shares (300,000 units at $16.00) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan exercised 3,108 shares at a strike of $3.79 and sold $65,501 worth of shares (3,631 units at $18.04), decreasing direct ownership by 0.25% to 209,641 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by President and COO Cohlhepp Ryan4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Mazumdar Claire4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Raben David4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Hyep Ivan4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Chief Legal Officer Meisner Lara4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan sold $69,296 worth of shares (3,828 units at $18.10), decreasing direct ownership by 2% to 210,164 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Financial Officer Hyep Ivan sold $34,162 worth of shares (1,882 units at $18.15) and exercised 1,882 shares at a strike of $3.79 (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan sold $2,685 worth of shares (149 units at $18.02), decreasing direct ownership by 0.07% to 213,992 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan exercised 25,000 shares at a strike of $4.44, increasing direct ownership by 13% to 214,141 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Medical Officer Raben David exercised 19,789 shares at a strike of $3.79, increasing direct ownership by 56% to 55,286 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Financial Officer Hyep Ivan exercised 9,200 shares at a strike of $3.79 and sold $168,492 worth of shares (9,200 units at $18.31) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Executive Officer Mazumdar Claire exercised 29,500 shares at a strike of $5.45, increasing direct ownership by 10% to 339,392 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan exercised 8,000 shares at a strike of $3.79 and sold $233,548 worth of shares (12,500 units at $18.68), decreasing direct ownership by 2% to 189,141 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Financial Officer Hyep Ivan exercised 18,400 shares at a strike of $3.79 and sold $341,074 worth of shares (18,400 units at $18.54) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan exercised 8,000 shares at a strike of $3.79 and sold $225,588 worth of shares (12,500 units at $18.05), decreasing direct ownership by 2% to 193,641 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Executive Officer Mazumdar Claire exercised 41,163 shares at a strike of $3.79 and sold $776,429 worth of shares (41,163 units at $18.86) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Medical Officer Raben David exercised 11,000 shares at a strike of $3.79 and sold $205,108 worth of shares (11,000 units at $18.65) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan exercised 8,000 shares at a strike of $3.79 and sold $226,942 worth of shares (12,500 units at $18.16), decreasing direct ownership by 2% to 198,141 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Executive Officer Mazumdar Claire exercised 24,734 shares at a strike of $3.79 and sold $466,936 worth of shares (24,734 units at $18.88) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Medical Officer Raben David exercised 22,000 shares at a strike of $3.79 and sold $405,900 worth of shares (22,000 units at $18.45) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Financial Officer Hyep Ivan exercised 6,415 shares at a strike of $3.79 and sold $116,931 worth of shares (6,415 units at $18.23) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Financial Officer Hyep Ivan exercised 30,385 shares at a strike of $3.79 and sold $553,198 worth of shares (30,385 units at $18.21) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- President and COO Cohlhepp Ryan exercised 32,000 shares at a strike of $3.79 and sold $911,842 worth of shares (50,500 units at $18.06), decreasing direct ownership by 8% to 202,641 units (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Legal Officer Meisner Lara exercised 33,807 shares at a strike of $9.24 and sold $498,653 worth of shares (33,807 units at $14.75) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Legal Officer Meisner Lara exercised 15,829 shares at a strike of $5.45 and sold $181,875 worth of shares (15,829 units at $11.49) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Legal Officer Meisner Lara sold $165,096 worth of shares (15,829 units at $10.43) and exercised 15,829 shares at a strike of $5.45 (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Haviland Kate4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Mazumdar-Shaw Kiran4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Powell Michael4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Lonberg Nils4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Robertson Scott M.4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Simson Jake4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Bowden Christopher4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Chief Legal Officer Meisner Lara sold $1,021,211 worth of shares (79,146 units at $12.90) and exercised 79,146 shares at a strike of $5.45 (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Possible Members of 10% Group Flynn James E converted options into 1,725,174 shares and bought $1,260,000 worth of shares (70,000 units at $18.00) (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Lonberg Nils4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by Director Simson Jake4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- Large owner Biocon Ltd converted options into 5,408,140 shares (SEC Form 4)4 - Bicara Therapeutics Inc. (0002023658) (Issuer)